(NASDAQ: LIFE) Atyr Pharma's forecast annual revenue growth rate of 431.52% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 35.39%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.64%.
Atyr Pharma's revenue in 2024 is $588,000.On average, 2 Wall Street analysts forecast LIFE's revenue for 2024 to be $25,327,015, with the lowest LIFE revenue forecast at $16,217,571, and the highest LIFE revenue forecast at $34,505,470. On average, 1 Wall Street analysts forecast LIFE's revenue for 2025 to be $869,537,844, with the lowest LIFE revenue forecast at $869,537,844, and the highest LIFE revenue forecast at $869,537,844.
In 2026, LIFE is forecast to generate $6,579,848,074 in revenue, with the lowest revenue forecast at $1,862,605,271 and the highest revenue forecast at $11,297,090,878.